Old Web
English
Sign In
Acemap
>
authorDetail
>
G. Kannourakis
G. Kannourakis
Medicine
Internal medicine
Pathology
Biology
Cutaneous squamous cell carcinoma
5
Papers
463
Citations
0.05
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
2014
British Journal of Cancer
B. Escudier
M. D. Michaelson
Robert J. Motzer
Thomas E. Hutson
Joseph I. Clark
Ho Yeong Lim
E. Porfiri
P. Zalewski
G. Kannourakis
Michael Staehler
Jamal Tarazi
Brad Rosbrook
Laura Cisar
Subramanian Hariharan
Sinil Kim
Brian I. Rini
Show All
Source
Cite
Save
Citations (82)
Three Cases of Activation of Cutaneous Squamous-cell Carcinoma During Treatment with Prolonged Administration of Rituximab
2006
Clinical Oncology
G.B. Fogarty
M. Bayne
P. Bedford
R. Bond
G. Kannourakis
Show All
Source
Cite
Save
Citations (17)
bcl-2 transgene expression can protect neurons against developmental and induced cell death
1995
Proceedings of the National Academy of Sciences of the United States of America
P.G. Farlie
Ralf Dringen
Sandra Rees
G. Kannourakis
Ora Bernard
Show All
Source
Cite
Save
Citations (253)
Kiz-1, a protein with LIM zinc finger and kinase domains, is expressed mainly in neurons
1994
Cell Growth & Differentiation
O. Bernard
Soula Ganiatsas
G. Kannourakis
Ralf Dringen
Show All
Source
Cite
Save
Citations (83)
Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group.
1994
Journal of Clinical Oncology
Les White
Geoffrey McCowage
G. Kannourakis
Vim Nayanar
L Colnan
Stuart Kellie
Peter J. Shaw
R. Seshadri
Liane Lockwood
K. Tiedemann
Show All
Source
Cite
Save
Citations (28)
1